- Home
- UGRO vs CPHI Comparison
UGRO vs CPHI Comparison
Compare UGRO & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UGRO
- CPHI
- Stock Information
- Founded
- UGRO 2014
- CPHI N/A
- Country
- UGRO United States
- CPHI China
- Employees
- UGRO N/A
- CPHI N/A
- Industry
- UGRO Industrial Specialties
- CPHI Biotechnology: Pharmaceutical Preparations
- Sector
- UGRO Consumer Discretionary
- CPHI Health Care
- Exchange
- UGRO Nasdaq
- CPHI Nasdaq
- Market Cap
- UGRO 5.5M
- CPHI 5.4M
- IPO Year
- UGRO N/A
- CPHI N/A
- Fundamental
- Price
- UGRO $0.38
- CPHI $2.31
- Analyst Decision
- UGRO Strong Buy
- CPHI
- Analyst Count
- UGRO 1
- CPHI 0
- Target Price
- UGRO $3.00
- CPHI N/A
- AVG Volume (30 Days)
- UGRO 316.8K
- CPHI 123.6K
- Earning Date
- UGRO 05-27-2025
- CPHI 05-23-2025
- Dividend Yield
- UGRO N/A
- CPHI N/A
- EPS Growth
- UGRO N/A
- CPHI N/A
- EPS
- UGRO N/A
- CPHI N/A
- Revenue
- UGRO $59,985,133.00
- CPHI $4,295,377.00
- Revenue This Year
- UGRO N/A
- CPHI N/A
- Revenue Next Year
- UGRO $31.25
- CPHI N/A
- P/E Ratio
- UGRO N/A
- CPHI N/A
- Revenue Growth
- UGRO N/A
- CPHI N/A
- 52 Week Low
- UGRO $0.37
- CPHI $1.20
- 52 Week High
- UGRO $2.16
- CPHI $4.10
- Technical
- Relative Strength Index (RSI)
- UGRO 37.32
- CPHI 62.79
- Support Level
- UGRO $0.38
- CPHI $2.08
- Resistance Level
- UGRO $0.43
- CPHI $2.50
- Average True Range (ATR)
- UGRO 0.04
- CPHI 0.22
- MACD
- UGRO 0.00
- CPHI 0.07
- Stochastic Oscillator
- UGRO 5.61
- CPHI 84.42
About UGRO urban-gro Inc.
Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.